• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
drug prices biologics drug costs IRA money cash payment co-pay
Special Reports

Top 20 pharma companies by 2025 revenue

2025 was a solid year overall in the biopharma industry as 16 of the world's top 20 companies achieved growth, led by Eli Lilly with a staggering 45% increase in revenue.
Kevin Dunleavy Apr 20, 2026 3:00am
dart board miss failure

Merck's Welireg surprisingly fails in first-line kidney cancer

Apr 21, 2026 10:00am
Brain Cancerjpg

Why Molecular Testing Is Key to Brain Cancer Diagnosis

Brought to you by Jazz Pharmaceuticals
merck

FDA signs off on Merck's HIV combo pill Idvynso

Apr 21, 2026 3:26pm
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Week 1 of Lilly's Foundayo launch

Apr 21, 2026 1:01pm
Graphic of a masculine figure walking out of an exit light pouring out

Pfizer's chief strategist Andrew Baum to step down: reports

Apr 21, 2026 11:24am
More News

AZ's Ultomiris hits goal in ph. 3 IgAN trial

Apr 21, 2026 10:35am

Roche's Enspryng cuts MOGAD relapse risk by 68% in phase 3

Apr 21, 2026 10:15am
Fierce Biotech

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am

Sanofi's new COVID shot tops Moderna's mNexspike in safety trial

Apr 20, 2026 10:52am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings